Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812818) titled 'MAGiC - Congenital Heart DIsease' on Sept. 1.

Study Type: Observational [Patient Registry]

Primary Sponsor: Stereotaxis

Condition: Supraventricular Tachycardia (SVT) Congenital Heart Disease (CHD)

Intervention: Device: Cardiac ablation using the MAGiC Ablation Catheter

Recruitment Status: Not recruiting

Date of First Enrollment: October 31, 2026

Target Sample Size: 40

To know more, visit https://clinicaltrials.gov/study/NCT07812818

Published by HT Digital Content Services with permission from Health Daily Digest....